Skip to Main Content
Biological & Biomedical Sciences
Yale Home

INFORMATION FOR

    Rory Shallis, MD

    Assistant Professor of Medicine (Hematology)
    DownloadHi-Res Photo

    Are You a Patient?

    View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.

    View Doctor Profile

    About

    Titles

    Assistant Professor of Medicine (Hematology)

    Biography

    Dr. Shallis received his MD from Rutgers-Robert Wood Johnson Medical School, completed his residency training at Brown University-Rhode Island Hospital and fellowship training at Yale-New Haven Hospital. 

    He is focused on the care and research of patients with myeloid malignancies, particularly acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS). He also participated in the K12 Calabresi Immuno-Oncology Training Program and currently participates as an investigator in several clinical trials aimed at improving the outcomes of patients with AML and MDS.

    Dr. Shallis also maintains research interest in epidemiological, outcomes and effectiveness research as it pertains to the hematologic malignancies with a goal of identifying barriers to effective care and ultimately strategies to improve the outcomes of patients with these malignant diseases. Dr. Shallis conducts research with the Cancer Outcomes, Public Policy and Effectiveness Research (COPPER) Center at Yale University. 

    Dr. Shallis has presented his research at multiple regional, national and international meetings and is a member of the National Comprehensive Cancer Network (NCCN) clinical guidelines for MDS and AML panels. He is an author on more than 75 peer-reviewed publications and book chapters, most of which as first author and has served as an ad hoc reviewer for many journals including Leukemia, Haematologica, Blood Advances, Leukemia Research, Leukemia & Lymphoma, Acta Haematologica, Hematology, Therapeutic Advances in Hematology, Expert Review of Hematology, BMC Hematology, eJHaem and Future Oncology among others.

    Appointments

    Other Departments & Organizations

    Education & Training

    Fellowship
    Yale - New Haven Hospital (2020)
    Internship
    Brown University - Rhode Island Hospital (2017)
    Residency
    Brown University - Rhode Island Hospital (2017)
    MD
    Rutgers University - Robert Wood Johnson Medical School (2014)
    BA
    Rutgers College, Cell Biology & Neuroscience Psychology (2010)

    Research

    Overview

    Medical Research Interests

    Epidemiology; Leukemia; Myelodysplastic Syndromes; Myelodysplastic-Myeloproliferative Diseases; Myeloproliferative Disorders

    Research at a Glance

    Yale Co-Authors

    Frequent collaborators of Rory Shallis's published research.

    Publications

    2024

    See All Publications

    Academic Achievements & Community Involvement

    • activity

      National Comprehensive Cancer Network (NCCN) - Myelodysplastic Syndromes Guideline Panel

      CommitteesMember
    • activity

      Older Adult AML Working Group - National Cancer Institute (NCI) Myeloid Precision Medicine Initiative

      Peer Review Groups and Grant Study SectionsMember
    • activity

      ECOG-ACRIN Leukemia Committee

      CommitteesMember
    • activity

      American Society of Hematology (ASH)

      Professional OrganizationsMember
    • activity

      American Society of Clinical Oncology (ASCO)

      Professional OrganizationsMember
    See All Achievements

    Clinical Care

    Overview

    Rory Shallis, MD, received his medical degree from Rutgers-Robert Wood Johnson Medical School, completed his residency training at Brown University-Rhode Island Hospital, and fellowship training at Yale New Haven Hospital.

    He is focused on the care and research of patients with myeloid malignancies, particularly acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS). He participated in the K12 Calabresi Immuno-Oncology Training Program and currently participates as an investigator in several clinical trials aimed at improving the outcomes of patients with AML and MDS.

    Dr. Shallis also maintains research interest in epidemiological, outcomes, and effectiveness research as it pertains to the hematologic malignancies with a goal of identifying barriers to effective care and ultimately strategies to improve the outcomes of patients with these malignant diseases. Dr. Shallis conducts research with the Cancer Outcomes, Public Policy and Effectiveness Research (COPPER) Center at Yale University.

    Dr. Shallis has presented his research at multiple regional, national, and international meetings and is a member of the National Comprehensive Cancer Network (NCCN) clinical guidelines for MDS and AML panels. He is an author on more than 75 peer-reviewed publications and book chapters, most of which as first author. He has served as an ad hoc reviewer for many journals including Leukemia, Haematologica, Blood Advances, Leukemia Research, Leukemia & Lymphoma, Acta Haematologica, Hematology, Therapeutic Advances in Hematology, Expert Review of Hematology, BMC Hematology, eJHaem, and Future Oncology.

    Clinical Specialties

    Hematology

    Fact Sheets

    See All Fact Sheets On Yale Medicine

    Board Certifications

    • Hematology (Internal Medicine)

      Certification Organization
      AB of Internal Medicine
      Original Certification Date
      2021

    • Internal Medicine

      Certification Organization
      AB of Internal Medicine
      Original Certification Date
      2017

    Yale Medicine News

    See All News On Yale Medicine

    Are You a Patient?

    View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.

    View Doctor Profile

    Get In Touch

    Contacts

    Email
    Appointment Number

    Locations

    • Patient Care Locations

      Are You a Patient? View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.

      See Patient Care Locations